JPWO2020022512A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020022512A5
JPWO2020022512A5 JP2020532522A JP2020532522A JPWO2020022512A5 JP WO2020022512 A5 JPWO2020022512 A5 JP WO2020022512A5 JP 2020532522 A JP2020532522 A JP 2020532522A JP 2020532522 A JP2020532522 A JP 2020532522A JP WO2020022512 A5 JPWO2020022512 A5 JP WO2020022512A5
Authority
JP
Japan
Prior art keywords
tcr
gene
cells
recombinase
drug resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020532522A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020022512A1 (ja
JP7422365B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/029537 external-priority patent/WO2020022512A1/ja
Publication of JPWO2020022512A1 publication Critical patent/JPWO2020022512A1/ja
Publication of JPWO2020022512A5 publication Critical patent/JPWO2020022512A5/ja
Application granted granted Critical
Publication of JP7422365B2 publication Critical patent/JP7422365B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020532522A 2018-07-26 2019-07-26 外来抗原レセプター遺伝子導入細胞の製造方法 Active JP7422365B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018140523 2018-07-26
JP2018140523 2018-07-26
PCT/JP2019/029537 WO2020022512A1 (ja) 2018-07-26 2019-07-26 外来抗原レセプター遺伝子導入細胞の製造方法

Publications (3)

Publication Number Publication Date
JPWO2020022512A1 JPWO2020022512A1 (ja) 2021-08-02
JPWO2020022512A5 true JPWO2020022512A5 (https=) 2022-08-02
JP7422365B2 JP7422365B2 (ja) 2024-01-26

Family

ID=69180441

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020532522A Active JP7422365B2 (ja) 2018-07-26 2019-07-26 外来抗原レセプター遺伝子導入細胞の製造方法

Country Status (7)

Country Link
US (1) US20210381008A1 (https=)
EP (1) EP3845638A4 (https=)
JP (1) JP7422365B2 (https=)
CN (1) CN112752838A (https=)
AU (1) AU2019312008B2 (https=)
SG (1) SG11202101789SA (https=)
WO (1) WO2020022512A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202006903D0 (en) * 2020-05-11 2020-06-24 Adaptimmune Ltd Modified iPSCs
WO2022059780A1 (ja) * 2020-09-18 2022-03-24 サイアス株式会社 ｉＰＳ細胞を介する再生Ｔ細胞の製造方法
EP4219707A4 (en) 2020-09-24 2024-11-13 Kyoto University METHOD FOR PRODUCING AN EFFECTOR CELL WITH DESIRED SPECIFICITY
KR20230118887A (ko) 2020-12-03 2023-08-14 센츄리 쎄라퓨틱스 인코포레이티드 유전자 조작 세포 및 이의 용도
US11661459B2 (en) 2020-12-03 2023-05-30 Century Therapeutics, Inc. Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
AR124414A1 (es) 2020-12-18 2023-03-22 Century Therapeutics Inc Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable
AU2022259170A1 (en) * 2021-04-16 2023-10-12 Thyas Co. Ltd. Cell bank composed of ips cells for introducing t cell receptor gene
CN118541475A (zh) * 2021-12-27 2024-08-23 亘喜生物科技（上海）有限公司 用于细胞修饰的系统和方法
KR20260047608A (ko) * 2023-08-04 2026-04-08 갓코호우징 도쿄리카다이가쿠 면역 세포의 제조 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2389251T3 (es) * 2000-12-19 2012-10-24 Altor Bioscience Corporation Animales transgénicos que comprenden un sistema inmunitario humanizado
JPWO2011096482A1 (ja) 2010-02-03 2013-06-13 国立大学法人 東京大学 多能性幹細胞を用いた免疫機能再建法
CN107858333B (zh) * 2011-10-28 2022-05-27 瑞泽恩制药公司 T细胞受体基因修饰小鼠
JP6164746B2 (ja) 2012-05-22 2017-07-19 国立大学法人 東京大学 抗原特異的ｔ細胞の製造方法
WO2014165707A2 (en) 2013-04-03 2014-10-09 Memorial Sloan-Kettering Cancer Center Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
US12194083B2 (en) * 2014-07-18 2025-01-14 Hiroshi Kawamoto Method for establishing pluripotent stem cells bearing genes encoding antigen specific T cell receptor
JPWO2016010153A1 (ja) 2014-07-18 2017-04-27 宏 河本 免疫細胞療法用ｔ細胞の誘導方法
AU2015290561A1 (en) 2014-07-18 2017-03-09 Hiroshi Kawamoto Method for generating pluripotent stem cells bearing antigen specific T cell receptor genes
CN105316362B (zh) * 2015-08-19 2020-03-17 暨南大学 一种Dual-RMCE介导的TCR基因置换系统及其方法
KR20250141836A (ko) * 2015-11-04 2025-09-29 페이트 세러퓨틱스, 인코포레이티드 만능 세포의 유전자 조작
EP4628587A3 (en) * 2016-04-15 2026-02-25 Memorial Sloan Kettering Cancer Center Transgenic t cell and chimeric antigen receptor t cell compositions and related methods
LT3444334T (lt) 2016-04-15 2021-12-10 Kyoto University Antigenui specifinių cd8 teigiamų t ląstelių indikavimo būdas

Similar Documents

Publication Publication Date Title
JPWO2020022512A5 (https=)
JP7401432B2 (ja) 操作されたｄｎａ結合タンパク質
AU2017217813B2 (en) VCN enhancer compositions and methods of using the same
JP2022097517A (ja) リンパ球における高レベル且つ安定な遺伝子移入のための方法
JP7422365B2 (ja) 外来抗原レセプター遺伝子導入細胞の製造方法
US20240336935A1 (en) Self-inactivating lentiviral vector comprising a foxp3 expression cassette
JP2020058398A (ja) 養子細胞治療製品を製造するための誘導多能性幹細胞の適用
JP2023501388A5 (https=)
JP2018518182A (ja) ゲノム編集のためのｃｒｉｓｐｒ／ｃａｓ９複合体
CN115362000A (zh) 使用多核苷酸沉默和替换的神经退行性病症的基因疗法
WO2017139561A1 (en) Vcn enhancer compositions and methods of using the same
JP2023530919A5 (https=)
US20050079616A1 (en) Method of transducing ES cells
US20040197317A1 (en) Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
JP7807756B2 (ja) 所望の特異性を有するエフェクター細胞の製造方法
WO2019062887A1 (zh) 一种体外产生环状核酸分子的方法
CN113444722B (zh) 单碱基编辑介导的剪接修复在制备治疗脊髓性肌萎缩症中的应用
JPWO2022065444A5 (https=)
JP6855579B2 (ja) Ｔ細胞を得る方法及び使用
US20260034174A1 (en) Methods and constructs for gene editing by coding sequence replacement
US20240287506A1 (en) Library construction method based on long overhang sequence ligation
JP2025520548A (ja) 改善されたエンハンサーおよびベクター
WO2024119157A1 (en) Lipid particles with cofusogens and methods of producing and using the same
WO2026008633A1 (en) Intronic targeted insertion of transgenes
AU2002351884B2 (en) Method of transducing ES cells